Answers are grounded in this paper and cite their sources.
While application of the algorithm to VigiBase allowed identification of some substandard medicines, some key prerequisites have been identified that need to be fulfilled at the national level for the algorithm to be useful in practice. Such key factors are fast handling and transfer of incoming reports into VigiBase, detailed information on the product and its distribution channels, the possibility of contacting primary reporters for further information, availability of samples of suspected products and laboratory capacity to analyse suspected products.
No takes yet. Share an insight, caveat, or question.
Juhlin et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: